Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Dec 9, 2009
Robert Henry, MD, from the University of California, San Diego discusses dual PPAR agonists and their potential for the treatment of type 2 diabetes and its cardiovascular comorbidities. Provided by the Institute for Diabetes, Obesity, and Cardiovascular Disease (iDOC), a free resource for continuing medical education and other tools for medical professionals focused on the treatment of these three related conditions. Visit www.idoc.org for more information.